心通医疗-B（02160.HK）：9月21日南向资金增持26.4万股

证券之星2023-09-22

9月21日北向资金增持26.4万股心通医疗-B（02160.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持313.3万股。近20个交易日中，获南向资金增持的有17天，累计净增持1628.0万股。截至目前，南向资金持有心通医疗-B（02160.HK）2.11亿股，占公司已发行普通股的8.72%。微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2369433416?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-09-22 05:51","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2369433416","market":"hk","top_or_hot":-1,"title":"心通医疗-B（02160.HK）：9月21日南向资金增持26.4万股","media":"证券之星","content":"<div>\n<p>9月21日北向资金增持26.4万股心通医疗-B（02160.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持313.3万股。近20个交易日中，获南向资金增持的有17天，累计净增持1628.0万股。截至目前，南向资金持有心通医疗-B（02160.HK）2.11亿股，占公司已发行普通股的8.72%。微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230922055152825f3fc1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>心通医疗-B（02160.HK）：9月21日南向资金增持26.4万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n心通医疗-B（02160.HK）：9月21日南向资金增持26.4万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-09-22 05:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230922055152825f3fc1&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>9月21日北向资金增持26.4万股心通医疗-B（02160.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持313.3万股。近20个交易日中，获南向资金增持的有17天，累计净增持1628.0万股。截至目前，南向资金持有心通医疗-B（02160.HK）2.11亿股，占公司已发行普通股的8.72%。微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230922055152825f3fc1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230922055152825f3fc1&s=b","article_id":"2369433416","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230922055152825f3fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2369433416","pubTimestamp":1695333100,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近20个交易日中，获南向资金增持的有17天，累计净增持1628.0万股。截至目前，南向资金持有心通医疗-B2.11亿股，占公司已发行普通股的8.72%。微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要于国内市场开展业务。以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1583":"高瓴概念","BK1574":"生物医药B类股","BK1100":"医疗保健设备","02160":"微创心通-B"},"translate_title":"Xintong Medical-B (02160. HK): On September 21, Southbound Capital increased its holdings by 264,000 shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02160":1},"content_text":"9月21日北向资金增持26.4万股心通医疗-B（02160.HK）。近5个交易日中，获南向资金增持的有4天，累计净增持313.3万股。近20个交易日中，获南向资金增持的有17天，累计净增持1628.0万股。截至目前，南向资金持有心通医疗-B（02160.HK）2.11亿股，占公司已发行普通股的8.72%。微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入（TAVI）产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。以上内容由证券之星根据公开信息整理，由算法生成，与本站立场无关。证券之星力求但不保证该信息（包括但不限于文字、视频、音频、数据及图表）全部或者部分内容的的准确性、完整性、有效性、及时性等，如存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2369433416","isCrawlerRequest":true}